Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (882)

Asciminib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Relatlimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-LAG-3 mAb

Goserelin Acetate

Hormonal Therapy

Therapeutic Category

Hormonal Therapy

Oncology Type

Solid Tumour (Prostate/Breast)

Drug Class / Mechanism

LHRH Agonist

Nilotinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Lorlatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

ALK / ROS1 / NTRK Inhibitor

Lutetium-177 Dotatate

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Amivantamab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager

Capivasertib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

AKT Inhibitor

Encorafenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor

Teclistamab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager

Abiraterone Acetate

Hormonal Therapy

Therapeutic Category

Hormonal Therapy

Oncology Type

Solid Tumour (Prostate)

Drug Class / Mechanism

CYP17 / Androgen Synthesis Inhibitor

Dasatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor